Qiagen (QGEN) Total Non-Current Liabilities (2009 - 2026)
Qiagen (QGEN) posted Total Non-Current Liabilities of $2.0 billion for Q4 2025, up 3.12% sequentially from $1.9 billion in Q3 2025, and up 84.3% YoY from $1.1 billion in Q4 2024.
Qiagen (QGEN) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends
Qiagen has reported Total Non-Current Liabilities for 17 years, with the latest figure at $2.0 billion in Q4 2025.
- Quarterly Total Non-Current Liabilities rose 84.3% year-over-year to $2.0 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.0 billion (up 84.3% YoY) and the FY2025 annual result came in at $2.0 billion, up 84.3% from the prior year.
- Total Non-Current Liabilities improved to $2.0 billion in Q4 2025 per QGEN's latest filing, from $1.9 billion in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at $2.4 billion in Q2 2021 and troughed at $1.1 billion in Q4 2024.
- A 5-year average of $1.7 billion and a median of $1.7 billion in 2022 frame the typical range for Total Non-Current Liabilities.
- The sharpest annual moves came in 2021 and 2025: Total Non-Current Liabilities slumped 38.67% in 2021, then jumped 84.3% in 2025.
- Over 5 years, Total Non-Current Liabilities stood at $1.5 billion in 2021, then climbed by 20.46% to $1.8 billion in 2022, then slumped by 33.49% to $1.2 billion in 2023, then declined by 12.04% to $1.1 billion in 2024, then surged by 84.3% to $2.0 billion in 2025.
- According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $2.0 billion, $1.9 billion, and $1.2 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.40 Bn | 209.33 Bn | 8.34 Bn | 108.64 Bn |
| 2 | Danaher | 139.94 Bn | 135.59 Bn | 3.61 Bn | 85.84 Bn |
| 3 | Idexx Laboratories | 46.03 Bn | 45.83 Bn | 779.09 Mn | 542.10 Mn |
| 4 | Agilent Technologies | 39.69 Bn | 37.88 Bn | 990.00 Mn | 5.45 Bn |
| 5 | Iqvia Holdings | 39.32 Bn | 37.24 Bn | 1.44 Bn | 22.94 Bn |
| 6 | Natera | 38.47 Bn | 37.37 Bn | 696.04 Mn | 737.18 Mn |
| 7 | Illumina | 29.98 Bn | 28.82 Bn | 770.00 Mn | 6.36 Bn |
| 8 | Mettler Toledo International | 28.57 Bn | 28.52 Bn | 650.22 Mn | 3.39 Bn |
| 9 | Quest Diagnostics | 26.21 Bn | 25.58 Bn | 1.03 Bn | 15.88 Bn |
| 10 | Qiagen | 8.62 Bn | 8.62 Bn | - | 5.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.79 Bn |
| Dec 31, 2025 | 1.99 Bn |
| Sep 30, 2025 | 1.93 Bn |
| Jun 30, 2025 | 1.19 Bn |
| Mar 31, 2025 | 1.62 Bn |
| Dec 31, 2024 | 1.08 Bn |
| Sep 30, 2024 | 1.61 Bn |
| Jun 30, 2024 | 1.14 Bn |
| Mar 31, 2024 | 1.18 Bn |
| Dec 31, 2023 | 1.23 Bn |
| Sep 30, 2023 | 1.69 Bn |
| Jun 30, 2023 | 1.75 Bn |
| Mar 31, 2023 | 1.83 Bn |
| Dec 31, 2022 | 1.85 Bn |
| Sep 30, 2022 | 1.69 Bn |
| Jun 30, 2022 | 1.91 Bn |
| Mar 31, 2022 | 1.99 Bn |
| Dec 31, 2021 | 1.53 Bn |
| Sep 30, 2021 | 1.96 Bn |
| Jun 30, 2021 | 2.43 Bn |